A separate study applying the similar principle also yielded beneficial outcome in APP/PS1 transgenic mice, a widely used mouse model for AD.24 This study provides clear evidence for the possibility of extending this design to other neurodegenerative diseases characterized by misfolded proteins, which is especially significant for a large number of the diseases that received less research attention due to low incidence. This evidence concerns the gene APP and neurodegenerative disease.